BIOCYTOGEN AND ACEPODIA JOIN FORCES TO ADVANCE BISPECIFIC ANTIBODY AND DUAL-PAYLOAD ADCS FOR TREATING COMPLEX TUMORS

Reuters · 01/07 22:00

Please log in to view news